US Stock MarketDetailed Quotes
ALT Altimmune
- 8.969
- +0.919+11.42%
Trading Nov 21 13:16 ET
637.92MMarket Cap-5712P/E (TTM)
8.980High7.910Low2.53MVolume8.050Open8.050Pre Close21.43MTurnover3.58%Turnover RatioLossP/E (Static)71.12MShares14.84052wk High4.78P/B633.18MFloat Cap2.76052wk Low--Dividend TTM70.60MShs Float978.000Historical High--Div YieldTTM13.29%Amplitude-1731.000Historical Low8.472Avg Price1Lot Size
Altimmune Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -32.37%-27.12M | 6.58%-18.11M | 15.72%-16.36M | -21.13%-75.81M | 4.47%-16.53M | -36.13%-20.49M | -16.04%-19.38M | -43.48%-19.41M | 20.01%-62.59M | 21.22%-17.31M |
| Net income from continuing operations | -10.52%-22.85M | -53.42%-24.64M | -21.52%-24.39M | -4.41%-88.45M | -46.08%-31.64M | 12.10%-20.67M | 20.12%-16.06M | -3.31%-20.07M | 12.75%-84.71M | 9.33%-21.66M |
| Operating gains losses | -500.00%-12K | 164.04%73K | 144.44%8K | -552.94%-154K | -109.22%-20K | 95.92%-2K | -375.00%-114K | 83.64%-18K | -91.15%34K | 149.43%217K |
| Depreciation and amortization | -68.38%37K | -49.59%61K | -14.40%107K | -3.25%477K | -75.32%114K | 182.98%117K | 128.30%121K | 5.04%125K | -10.53%493K | 294.87%462K |
| Other non cash items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -87.71%86K | --0 |
| Change In working capital | -224.39%-6.4M | 157.50%3.16M | 421.60%5.26M | -158.64%-8.27M | -66.91%821K | -130.21%-1.97M | -916.48%-5.49M | -128.96%-1.63M | 5,721.91%14.11M | 194.69%2.48M |
| -Change in receivables | 59.71%-328K | -25.87%-433K | 373.98%2.27M | -170.10%-2.31M | -117.88%-324K | -146.70%-814K | -1,395.65%-344K | -254.70%-830K | -49.53%3.3M | -65.23%1.81M |
| -Change in prepaid assets | 112.72%228K | 80.75%-354K | 154.63%4.05M | -150.75%-1.35M | 225.99%698K | -829.02%-1.79M | -623.93%-1.84M | -47.83%1.59M | 144.85%2.65M | 14.11%-554K |
| -Change in payables and accrued expense | -1,091.65%-6.3M | 219.27%3.94M | 55.50%-1.07M | -156.56%-4.62M | -63.45%447K | -87.24%635K | -280.88%-3.31M | -184.56%-2.39M | 1,030.79%8.16M | 117.02%1.22M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -32.37%-27.12M | 6.58%-18.11M | 15.72%-16.36M | -21.13%-75.81M | 4.47%-16.53M | -36.13%-20.49M | -16.04%-19.38M | -43.48%-19.41M | 20.01%-62.59M | 21.22%-17.31M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -72.76%1.2M | -192.70%-3.7M | -397.11%-39.52M | 118.71%13.73M | -911.31%-7.96M | 117.33%4.4M | 108.14%3.99M | 147,900.00%13.3M | -183.86%-73.4M | -96.06%981K |
| Net PPE purchase and sale | --0 | --0 | --0 | 62.70%-47K | --0 | --0 | 121.05%4K | -466.67%-51K | 98.96%-126K | 74.15%-38K |
| Net investment purchase and sale | -72.76%1.2M | -192.79%-3.7M | -395.97%-39.52M | 118.81%13.78M | -881.06%-7.96M | 117.37%4.4M | 108.14%3.98M | --13.35M | -173.39%-73.27M | -95.93%1.02M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -72.76%1.2M | -192.70%-3.7M | -397.11%-39.52M | 118.71%13.73M | -911.31%-7.96M | 117.33%4.4M | 108.14%3.99M | 147,900.00%13.3M | -183.86%-73.4M | -96.06%981K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -54.76%266K | -100.35%-46K | 13.58%-261K | 51.64%86.11M | 169,295.35%72.75M | -98.17%588K | -39.47%13.07M | -109.49%-302K | -12.78%56.78M | -100.34%-43K |
| Net common stock issuance | -77.80%131K | --0 | 25.19%169K | 54.07%86.82M | --72.74M | -98.15%590K | -45.14%13.35M | 19.47%135K | -13.37%56.35M | --0 |
| Proceeds from stock option exercised by employees | --139K | --198K | 178.69%170K | -88.11%113K | -36.59%52K | --0 | --0 | -98.09%61K | 439.77%950K | 7.89%82K |
| Net other financing activities | -100.00%-4K | 14.98%-244K | -20.48%-600K | -59.69%-824K | 70.40%-37K | 98.10%-2K | -71.86%-287K | -318.49%-498K | -337.29%-516K | ---125K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -54.76%266K | -100.35%-46K | 13.58%-261K | 51.64%86.11M | 169,295.35%72.75M | -98.17%588K | -39.47%13.07M | -109.49%-302K | -12.78%56.78M | -100.34%-43K |
| Net cash flow | ||||||||||
| Beginning cash position | -44.17%57.17M | -24.55%79.02M | 21.62%135.16M | -41.61%111.13M | -31.85%86.9M | -24.65%102.39M | -41.81%104.72M | -41.61%111.13M | 64.15%190.34M | -27.10%127.5M |
| Current changes in cash | -65.54%-25.65M | -837.37%-21.85M | -776.21%-56.14M | 130.34%24.03M | 394.86%48.26M | -84.64%-15.5M | 94.71%-2.33M | 38.12%-6.41M | -206.48%-79.2M | -206.03%-16.37M |
| End cash Position | -63.73%31.52M | -44.17%57.17M | -24.55%79.02M | 21.62%135.16M | 21.62%135.16M | -31.85%86.9M | -24.65%102.39M | -41.81%104.72M | -41.61%111.13M | -41.61%111.13M |
| Free cash flow | -32.37%-27.12M | 6.56%-18.11M | 15.94%-16.36M | -20.96%-75.86M | 4.68%-16.53M | -35.59%-20.49M | -15.88%-19.38M | -43.76%-19.46M | 30.74%-62.71M | 21.59%-17.34M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
